The summary below is from the full report titled “Zoledronic Acid Prevents Bone Loss after Liver Transplantation. A Randomized, Double-Blind, Placebo-Controlled Trial.” It is in the 21 February 2006 issue of Annals of Internal Medicine (volume 144, pages 239-248). The authors are B.A.L. Crawford, C. Kam, J. Pavlovic, K. Byth, D.J. Handelsman, P.W. Angus, and G.W. McCaughan.
Zolendronic Acid Prevents Bone Loss after Liver Transplantation. Ann Intern Med. 2006;144:I–37. doi: https://doi.org/10.7326/0003-4819-144-4-200602210-00002
Download citation file:
Published: Ann Intern Med. 2006;144(4):I-37.
Endocrine and Metabolism, Gastroenterology/Hepatology, Liver Disease, Liver Transplantation, Metabolic Bone Disorders.
Results provided by:
Copyright © 2020 American College of Physicians. All Rights Reserved.
Print ISSN: 0003-4819 | Online ISSN: 1539-3704
Conditions of Use